AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B ...Middle East

SAN FRANCISCO, Dec. 26, 2024 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure for chronic...

Read More Details
Finally We wish PressBee provided you with enough information of ( AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B )

Also on site :

• Country Superstars Announce Christmas Residency at Ryman Auditorium
• Trump announces Iran and Israel have agreed to a “Complete and Total CEASEFIRE"
• ‘This is about more than burgers and fries’: Boycott of McDonald’s to begin this week